← Pharmaceutical Science Advances
Papers in Pharmaceutical Science Advances
Page 1 · newest first
- The substrate envelope strategy: Structural basis for resistance mitigation in antiviral drug designPharmaceutical Science Advances · 2026
- Gut Microbiota-Mediated Uric Acid Metabolism: Novel Insights for Developing Urate-Lowering and Anti-Gout MedicationsPharmaceutical Science Advances · 2026
- The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptidesPharmaceutical Science Advances · 2026
- Quorum Sensing Inhibitor-Antibiotic Conjugate Suppresses Virulence and Eradicates Intracellular Staphylococcus aureusPharmaceutical Science Advances · 2026
- Xiangsha Liujunzi Tang: A Promising Traditional Chinese Herbal Formula for Healing Gastric Mucosal Injury Through Pyroptosis Pathway ModulationPharmaceutical Science Advances · 2026
- Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPDPharmaceutical Science Advances · 2026
- From barrier to guide: Exploiting disease-specific hemodynamics for enhanced nanodrug targeting in cardiovascular diseasesPharmaceutical Science Advances · 2026
- A visualizable mitochondrial-targeted Chlorambucil prodrug for enhancing anti-hepatoma efficacyPharmaceutical Science Advances · 2026
- The gut-lung axis and viral pneumonia: Unrevealing the gut microbiotaPharmaceutical Science Advances · 2026
- Co-assembly of dipeptide and hydrophobic drug in hyaluronic acid through Schiff base reaction for the treatment of osteoarthritisPharmaceutical Science Advances · 2026
- In vivo immune cell engineering from bench to clinical realityPharmaceutical Science Advances · 2026
- Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectivesPharmaceutical Science Advances · 2026
- Calcium overload-induced apoptosis in cancer cells: ER-mitochondria crosstalk and therapeutic implicationsPharmaceutical Science Advances · 2026
- Recent Advances in HER2-Targeted Inhibitors for Cancer TherapyPharmaceutical Science Advances · 2026
- BGC1201: A potent allosteric SHP2 inhibitor with broad antitumor activity in lung, pancreatic, and esophageal cancer xenograftsPharmaceutical Science Advances · 2026
- Therapeutic potential of the sphingosine kinase 2 inhibitor opaganibPharmaceutical Science Advances · 2026
- Bio-based nanomaterials in drug delivery: An updated reviewPharmaceutical Science Advances · 2026
- Discovery of Novel Kir4.1 Inhibitors Based on Serdemetan with Potential Therapy for Glioblastoma-Depression ComorbidityPharmaceutical Science Advances · 2026
- Repurposing Radiopharmaceutical Carriers for Targeted Drug Delivery and Theranostics: A Translational FrameworkPharmaceutical Science Advances · 2026
- Uncovering a photoprotective polysaccharide from Gentiana dahurica via systematic fractionationPharmaceutical Science Advances · 2026
- The design and performing of animal experiments were approved by the Institutional Animal Care and Use Committees at Shandong University. APPROVAL NUMBER: KYLL-2023(ZM)-576.Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathwaysPharmaceutical Science Advances · 2026
- Artificial Intelligence-Driven Discovery of Coumarin-Based Therapeutics: Revolutionizing Target Identification and ValidationPharmaceutical Science Advances · 2026
- Functional identification of key enzymes in calycosin biosynthesis in Astragalus membranaceus and establishment of heterologous expression systemPharmaceutical Science Advances · 2026
- Toxicity of nanostructures in drug delivery applicationsPharmaceutical Science Advances · 2026
- Unleashing the Power of DNA-Encoded Libraries for Challenging Targets in Drug DiscoveryPharmaceutical Science Advances · 2026
- Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discoveryPharmaceutical Science Advances · 2026
- Qualitative and quantitative standardisation of Epilobium angustifolium L. leaves according to Pharmacopoeial requirementsPharmaceutical Science Advances · 2026
- Recent advances in chemiluminescence probes for Tumor microenvironment with applications in cancer diagnosis and therapyPharmaceutical Science Advances · 2026
- Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugsPharmaceutical Science Advances · 2026
- NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCLPharmaceutical Science Advances · 2026
- Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapyPharmaceutical Science Advances · 2026
- The bidirectional interface between oral drug and the gut microbiome: Implications for drug deliveryPharmaceutical Science Advances · 2026
- Computational screening of Sophora flavescens phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studiesPharmaceutical Science Advances · 2026
- Metabolomic profiling of Musanga cecropioides leaf extract reveals cytotoxic mechanisms in MCF-7 breast cancer cellsPharmaceutical Science Advances · 2025
- Graminoides A-D, antibacterial cyclic octaketides from the desert-derived StreptomycesPharmaceutical Science Advances · 2025
- Convergence of computer-aided drug discovery and artificial intelligence: Towards next-generation therapeuticsPharmaceutical Science Advances · 2025
- Curcumin-loaded gelatin ethosomal gel: A novel approach for anti-inflammatory efficacyPharmaceutical Science Advances · 2025
- Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effectsPharmaceutical Science Advances · 2025
- Metal-organic frameworks in pharmaceutical researchPharmaceutical Science Advances · 2025
- Conquering viral drug resistance: Structural and mechanistic paradigms for antiresistance drug designPharmaceutical Science Advances · 2025
- Curative antimalarial efficacy and hepato-renal protective effects of Melochia umbellata leaf extract in rats infected with Plasmodium bergheiPharmaceutical Science Advances · 2025
- A biodegradable antimicrobial oligomer-containing hydrogel for drug-resistant bacteria-infected skin wound treatmentPharmaceutical Science Advances · 2025
- The applications of single-cell multiomics in drug screeningPharmaceutical Science Advances · 2025
- Targeted RNA base editing for therapeutic: mechanisms and advancesPharmaceutical Science Advances · 2025
- Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancerPharmaceutical Science Advances · 2025
- An investigation into the underlying mechanisms of risperidone-induced antinociception through the cholinergic pathwayPharmaceutical Science Advances · 2025
- Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizationsPharmaceutical Science Advances · 2025
- Circular RNA: From non-coding regulators to functional protein encodersPharmaceutical Science Advances · 2025
- Phenol and chromone compounds for in silico inhibition of nsP2 and nsP3 of Chikungunya virusPharmaceutical Science Advances · 2025
- Protective activity of Basella alba l. Leaf extract on cardiac injury markers following intestinal ischemia-reperfusion: potential for cardiovascular therapyPharmaceutical Science Advances · 2025